Mucin gene expression in cardiac myxoma

International Journal of Clinical Practice

Volumn 58, Issue 3, 2004, Pages 306-309

  Chu, Pao Hsien ^a   Jung, S M ^b   Yeh, C H ^b   Yeh, T S ^b   Wang, C L ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Cardiac myxoma; Mitral valve myxoma; Mucin gene

Indexed keywords

MUCIN; MUCIN 1; MUCIN 2; MUCIN 5AC;

AGED; ARTICLE; BENIGN TUMOR; CARCINOGENESIS; CASE REPORT; CELL DIFFERENTIATION; CELL SPECIFICITY; GENE EXPRESSION; HEART LEFT ATRIUM; HEART MYXOMA; HEART SURGERY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MITRAL VALVE; PREVALENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; TISSUE SPECIFICITY; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TUMOR LOCALIZATION;

AGED; FEMALE; GENE EXPRESSION; HEART ATRIA; HEART NEOPLASMS; HUMANS; MITRAL VALVE; MUCINS; MYXOMA; NEOPLASM PROTEINS;

EID: 2342441492     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1368-5031.2004.00042.x     Document Type: Article

References (25)

1. Burke AP, Virmani R. Cardiac myxoma. A clinicopathologic study. Am J Clin Pathol 1993; 100 (6): 671-80.
2. Reynen K. Cardiac myxomas. N Engl J Med 1995; 333 (24): 1610-7.
3. Pucci A, Gagliardotto P, Zanini C, Pansini S, di Summa M, Mollo F. Histopathologic and clinical characterization of cardiac myxoma: review of 53 cases from a single institution. Am Heart J 2000; 140 (1): 134-8.
4. Pinede L, Duhaut P, Loire R. Clinical presentation of left atrial cardiac myxoma. A series of 112 consecutive cases. Medicine (Baltimore) 2001; 80 (3): 159-72.
5. Sadeghi N, Sadeghi S, Karimi A. Mitral valve recurrence of a left atrial myxoma. Eur J Cardiothorac Surg 2002; 21 (3): 568-73.
6. Suzuki J, Takayama K, Mitsui F et al. In situ interleukin-6 transcription in embryonic nonmuscle myosin heavy chain expressing immature mesenchyme cells of cardiac myxoma. Cardiovasc Pathol 2000; 9 (1): 33-7.
7. Landon G, Ordonez NG, Guarda LA. Cardiac myxomas. An immunohistochemical study using endothelial, histiocytic, and smooth-muscle cell markers. Arch Pathol Laboratory Med 1986; 110 (2): 116-20.
8. Kono T, Koide N, Hama Y et al. Expression of vascular endothelial growth factor and angiogenesis in cardiac myxoma: a study of fifteen patients. J Thorac Cardiovasc Surg 2000; 119 (1): 101-7.
9. Fujisawa H, Koide N, Kono T et al. Expression of basic fibroblast growth factor and its receptor-1 in cardiac myxoma. J Cardiovasc Surg (Torino) 2002; 43 (5): 589-94.
10. Acebo E, Val-Bernal JF, Gomez-Roman JJ. Thrombomodulin, calretinin and c-kit (CD117) expression in cardiac myxoma. Histol Histopathol 2001; 16 (4): 1031-6.
11. Deshpande A, Venugopal P, Kumar AS, Chopra P. Phenotypic characterization of cellular components of cardiac myxoma: a light microscopy and immunohistochemistry study. Hum Pathol 1996; 27 (10): 1056-9.
12. Goldman BI, Frydman C, Harpaz N, Ryan SF, Loiterman D. Glandular cardiac myxomas. Histologic, immunohistochemical, and ultrastructural evidence of epithelial differentiation. Cancer 1987; 59 (10): 1767-75.
13. Terracciano LM, Mhawech P, Suess K et al. Calretinin as a marker for cardiac myxoma. Diagnostic and histogenetic considerations. Am J Clin Pathol 2000; 114 (5): 754-9.
14. Scarpelli M, Montironi R, Ricciuti R, Vecchioni S, Pauri F. Cardiac myxoma with glandular elements metastatic to the brain 12 years after the removal of the original tumor. Clin Neuropathol 1997; 16 (4): 190-4.
15. Mendoza CE, Rosado MF, Bernal L. The role of interleukin-6 in cases of cardiac myxoma. Clinical features, immunologic abnormalities, and a possible role in recurrence. Tex Heart Inst J 2001; 28 (1): 3-7.
16. Kodama H, Hirotani T, Suzuki Y, Ogawa S, Yamazaki K. Cardiomyogenic differentiation in cardiac myxoma expressing lineage-specific transcription factors. Am J Pathol 2002; 161 (2): 381-9.
17. Moniaux N, Escande F, Porchet N, Aubert JP, Batra SK. Structural organization and classification of the human mucin genes. Front Biosci 2001; 6: D1192-1206.
18. Gum JR Jr. Human mucin glycoproteins: varied structures predict diverse properties and specific functions. Biochem Soc Trans 1995; 23 (4): 795-9.
19. Copin MC, Buisine MP, Devisme L et al. Normal respiratory mucosa, precursor lesions and lung carcinomas: differential expression of human mucin genes. Front Biosci 2001; 6: D1264-75.
20. Porchet N, Buisine MP, Desseyn JL et al. MUC genes: a superfamily of genes? Towards a functional classification of human apomucins. J Soc Biol 1999; 193 (1): 85-99.
21. Corfield AP, Carroll D, Myerscough N, Probert CS. Mucins in the gastrointestinal tract in health and disease. Front Biosci 2001; 6: D1321-57.
22. Yonezawa S, Sato E. Expression of mucin antigens in human cancers and its relationship with malignancy potential. Pathol Int 1997; 47: 813-30.
23. Rahn JJ, Dabbagh L, Pasdar M, Hugh JC. The importance of MUC1 cellular localization in patients with breast carcinoma: an immunohistologic study of 71 patients and review of the literature. Cancer 2001; 91: 1973-82.
24. Ookawa K, Kudo T, Aizawa S, Saito H, Tsuchida S. Transcriptional activation of the MUC2 gene by p53. J Biol Chem 2002; 277: 48270-5.
25. Ohmori H, Dohrman AF, Gallup M et al. Molecular cloning of the amino-terminal region of a rat MUC2 mucin gene homologue. Evidence for expression in both intestine and airway. J Biol Chem 1994; 269 (27): 17833-40.